Christopher Reading
21Patents
14h-index
17Co-inventors
78Inventor score
Filing activity: Sep 24, 1976 → Nov 17, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4474893A | Recombinant monoclonal antibodies | Emerging Cross-Sectional Technologies | 372 | Expired |
| US4714681A | Quadroma cells and trioma cells and methods for the production of same | Emerging Cross-Sectional Technologies | 147 | Expired |
| US4920061A | Biological magnetic colloids | Physics | 69 | Expired |
| US4110165A | Process for the production of clavulanic acid | Emerging Cross-Sectional Technologies | 44 | Expired |
| US4427690A | Esters of clavulanic acid | Emerging Cross-Sectional Technologies | 40 | Expired |
| US7547687B2 | Therapeutic treatment methods | Human Necessities | 32 | Active |
| US4525352A | Antibiotics | Emerging Cross-Sectional Technologies | 25 | Expired |
| US4560552A | Antibiotics | Emerging Cross-Sectional Technologies | 19 | Expired |
| US4529720A | Antibiotic from Streptomyces clavulicerus | Chemistry; Metallurgy | 18 | Expired |
| US4927502A | Methods and apparatus using galvanic immunoelectrodes | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6218380A | Pharmaceutical compositions | Chemistry; Metallurgy | 17 | Expired |
| US6048977A | Clavulanic acid and salts thereof | Chemistry; Metallurgy | 17 | Expired |
| US6051703A | Purified clavulanic acid and salts thereof | Chemistry; Metallurgy | 16 | Expired |
| US6031093A | Solid salts of clavulanic acid | Chemistry; Metallurgy | 16 | Expired |
| US4525353A | Antibiotics | Chemistry; Metallurgy | 7 | Expired |
| US7723532B2 | Pharmaceutical compositions 3 | Emerging Cross-Sectional Technologies | 5 | Active |
| US4526783A | Antibiotic from S. clavuligerus | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8354396B2 | Drug identification and treatment method | Physics | 4 | Active |
| US4556559A | Antibiotics | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8217025B2 | Drug screening and treatment methods | Physics | 3 | Active |
| US8486926B2 | Steroid tetrol solid state forms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.